This session’s featured segments include:
- In the Spotlight: Reviewing Your Summary Plan Descriptions: The Who, What, When, Why, and How
A brief overview of summary plan descriptions, including what material they should contain and how it should be organized, who should receive them and what distribution methods are allowed, when and under what circumstances they need to be provided, and the consequences of making mistakes. - HRAs and FSAs: An Update on the Current Legal Requirements
Over the past year and a half, the IRS has issued guidance about HRAs and FSAs, including the recently permitted $500 carryover rule. We will discuss the current state of the law so that you can ensure your medical reimbursement account plans are in compliance with legal requirements. - Year-End Amendments
This segment will discuss all the retirement and health and welfare amendments that are required to be signed before December 31, 2014.
Speakers
- Leigh C. Riley, Partner, Foley & Lardner LLP
- Katherine L. Aizawa, Special Counsel, Foley & Lardner LLP
- Isaac J. Morris, Senior Counsel, Foley & Lardner LLP
People
Related Insights
June 3, 2025
Foley Corporate Governance Update
Texas Senate Bill 2337: Protecting Texas Companies and Their Directors, Shareholders and Boards from Proxy Advice Not in the Financial Interests of Shareholders
On June 2, 2025, the Texas Legislature passed Senate Bill 2337, meaningfully regulating proxy advisors like ISS and Glass Lewis when providing proxy voting recommendations concerning Texas companies.
September 25, 2025
Events
Unclaimed Property Roundtable with Delaware State Escheator and Leading Practitioners
June 3, 2025
Health Care Law Today
GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health
Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for metabolic disorders, particularly type 2 diabetes and obesity.